Pingora Partners LLC acquired a new position in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 20,684 shares of the biopharmaceutical company’s stock, valued at approximately $1,061,000. Bristol-Myers Squibb comprises about 0.9% of Pingora […]